National Pharmaceuticals Strategy Reports

National Pharmaceuticals Strategy Conference Report:

Canada’s National Pharmaceuticals Strategy (NPS) contains the following elements:

1. Develop, assess and cost options for catastrophic pharmaceutical coverage
2. Establish a common national drug formulary for participating jurisdictions based on safety and cost effectiveness
3. Accelerate access to breakthrough drugs for unmet health needs through improvements to the drug approval process
4. Strengthen evaluation of real-world drug safety and effectiveness
5. Pursue purchasing strategies to obtain best prices for Canadians for drugs and vaccines
6. Enhance action to influence the prescribing behaviour of health care professionals so that drugs are used only when needed and the right drug is used for the right problem
7. Broaden the practice of e-prescribing through accelerated development and deployment of the Electronic Health Record
8. Accelerate access to non-patented drugs and achieve international parity on prices of non-patented drugs
9. Enhance analysis of cost drivers and cost-effectiveness, including best practices in drug plan policies

The Centre for Health Services and Policy Research at the University of British Columbia is hosting a conference in Vancouver on February 9th and 10th entitled “Towards a National Pharmaceuticals Strategy – Lessons from Abroad.”The conference will feature speakers who are involved in drug plan management from Canada, Australia, New Zealand and the United Kingdom.

Here are some of the topics on the agenda:

Evidence, Economics and Values in Coverage Decisions
National Drug Assessment: Challenges, Opportunities for Cooperation?
National Formularies and Price Regulation
Promoting Quality Use of Medicines
Drug Promotion: Threat to Quality?
Improving Canada's Drug Safety Regulation
Real-World Evaluation of Safety and Effectiveness
Pharmaceutical Policy Reform: Are There Any Ways Forward?

There is also a poster session covering topics such as:

Catastrophic Pharmaceutical Coverage
National Drug Formularies: Ensuring Safety and Cost Effectiveness
Breakthrough Drugs and the Approval Process
Evaluating Real-World Drug Safety and Effectiveness
Optimizing Prescribing Behaviour: The Right Drug at the Right Time
Cost Drivers and Cost-Effectiveness: Best Practices in Drug Plan Policies

Clearly, much will be discussed at this conference and Canadian jurisdictions may blend initiatives from other countries into the future of Canada’s drug plan management system.

George Wyatt will be attending this conference and will be writing a comprehensive report.The report will provide you with an understanding of the key learnings and perspectives associated with the program and will augment your understanding of the issues.

Wyatt Health Management is pleased to offer this report at a pre-conference price of $250.00 plus GST.

George Wyatt

905-257-5670

george.wyatt@wyatthealth.com

Roger MacPhee

519-341-9325

roger.macphee@wyatthealth.com